뒤로
Anthera Pharmaceuticals Inc(ANTH) 가격
ANTH 주가 차트
ANTH 수입
Anthera Pharmaceuticals Inc
$0
0%
$0
종가: Feb 06, 16:00:00 GMT-5
$0
0%
$0
애프터마켓: Feb 06, 20:00:00 GMT-5
아직 데이터 없음Earnings FAQ
ANTH의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Anthera Pharmaceuticals Inc ANTH의 지난 분기 매출 실적은 어땠나요?
Anthera Pharmaceuticals Inc의 매출 추정치는 얼마인가요?
Anthera Pharmaceuticals Inc의 수익 품질 점수는 얼마인가요?
Anthera Pharmaceuticals Inc는 언제 수익을 보고하나요?
Anthera Pharmaceuticals Inc의 예상 수익은 얼마인가요?
Anthera Pharmaceuticals Inc은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$0.0001
시가
$0.0001
일일 범위
$0.0001 - $0.0001
52주 범위
$0.0001 - $0.001
거래량
23.8K
평균 거래량
5.4K
EPS(TTM)
-1.63
배당수익률
--
시가총액
$2.6K
ANTH란 무엇인가요?
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines to treat serious and life-threatening diseases. The company is headquartered in Hayward, California and currently employs 21 full-time employees. The company went IPO on 2010-03-02. The firm has two Phase III product candidates, liprotamase also known as Sollpura and blisibimod. Sollpura is a non-porcine investigational Pancreatic Enzyme Replacement Therapy (PERT) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (EPI), often seen in patients with cystic fibrosis and other conditions. Blisibimod targets B-cell activating factor (BAFF), which has been shown to be elevated in a range of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (SLE), or lupus, Immunoglobulin A nephropathy (IgA) nephropathy, lupus nephritis and others.